Baolingbao Biology Co.Ltd(002286) : it is proposed to transfer 30% equity of Shanghai Mamba

On the evening of February 8, Baolingbao Biology Co.Ltd(002286) announced that its wholly-owned subsidiary, Shandong Baolingbao Biology Co.Ltd(002286) Beijian Food Co., Ltd., plans to transfer its 30% equity of Shanghai Mamba manba Health Technology Co., Ltd. to Shanghai ruixikang Medical Technology Co., Ltd., with a transfer amount of 4.8 million yuan. Previously, Beijian food held 30% equity of Shanghai Mamba. After the completion of this transaction, Beijian food will no longer hold the equity of Shanghai Mamba.